S063 Drug Monitoring Guidelines
DESCRIPTION
This symposium will focus on drug monitoring guidelines for the most commonly used immunomodulatory agents. This includes systemic corticosteroids, cyclosporine, synthetic immunosuppressive medications, biologics, JAK inhibitors, IVIG and anti-CD20 therapies. Guidelines for preventing side effects such as vaccination recommendations for patients on immunosuppressive therapy will also be discussed.
LEARNING OBJECTIVES
Select the appropriate laboratory work up for systemic immunomodulatory therapy.
Recognize side effects from systemic immunomodulatory therapy.
Identify risk factors for side effects from systemic immunomodulatory therapy.
SCHEDULE
1:00 PM
Introduction
Adela Rambi G. Cardones, MD, FAAD
1:05 PM
Cyclosporine
Jesse J. Keller, MD, MCR, FAAD
1:25 PM
Biologics
Ahmed Badawi, MD, PhD, FAAD
1:45 PM
Conventional DMARDs
Ting Wang-Weinman, PhD, MD, FAAD
2:05 PM
JAK Inhibitors
Anne Louise Marano, MD, FAAD
2:25 PM
Biologics in the Pediatric Population
George K. Hightower, MD, FAAD
2:45 PM
Prednisone
Anna Haemel, MD, FAAD
3:15 PM
IVIG, Anti-CD20 Biologics and Vaccination Recommendations for Immunosuppressed Adults
Adela Rambi G. Cardones, MD, FAAD
3:35 PM
Q and A
DIRECTOR
Adela Rambi G. Cardones, MD, FAAD
SPEAKERS
Ahmed Badawi, MD, PhD, FAAD
Anna Haemel, MD, FAAD
George K. Hightower, MD, FAAD
Jesse J. Keller, MD, MCR, FAAD
Anne Louise Marano, MD, FAAD
Ting Wang-Weinman, PhD, MD, FAAD
DISCLOSURES
Ahmed Badawi, MD, PhD, FAAD
Blueprint Medicines – Advisory Board(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria);
Adela Rambi G. Cardones, MD, FAAD
Leo Foundation – Investigator(Grants/Research Funding);
Anna Haemel, MD, FAAD
AstraZeneca – Investigator(Fees); Celldex – Investigator(Grants/Research Funding); CSL Behring – Data Safety Monitoring Board(Honoraria); Eli Lilly – Stockholder Public Company(Stock); Galderma – Investigator(Grants/Research Funding); Insmed – Investigator(Fees); Priovant Therapeutics – Advisory Board(Honoraria), Investigator(Fees);
George K. Hightower, MD, FAAD
No financial relationships exist with ineligible companies.
Jesse J. Keller, MD, MCR, FAAD
Galderma USA – Speaker(Honoraria);
Anne Louise Marano, MD, FAAD
Biogen – Investigator(Grants/Research Funding); Bristol Myers Squibb – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Fees); Priovant Therapeutics – Investigator(Grants/Research Funding);
Ting Wang-Weinman, PhD, MD, FAAD
No financial relationships exist with ineligible companies.